C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/06 (2006.01) A61K 38/08 (2006.01) A61P 3/10 (2006.01) A61P 11/06 (2006.01) A61P 29/00 (2006.01) C07K 7/18 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2423876
The present invention provides for a novel peptidic antagonist for the bradykinin B1 (BKB1) receptor having very good to excellent affinities and selectivity for the BKB, receptor, in vitro and in vivo increase resistance to enzymatic degradation, superior pharmacokinetic properties, capability to significantly reduce microvascular leakage observed alongside diabetic-induced increase in vascular permeability, capability to significantly reduced the state of hyperalgesia alongside diabetes, capability to significantly reduce the infiltration of pro- inflammatory cells and general state of inflammation alongside allergic asthma.
Gabra Bichoy
Gobeil Fernand
Neugebauer Witold A.
Regoli Domenico
Sirois Pierre
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Societe de Commercialisation Des Produits de La Recherche Appliq
Universite de Sherbrooke
LandOfFree
Novel selective bradykinin (bk) b1 peptidic receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel selective bradykinin (bk) b1 peptidic receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel selective bradykinin (bk) b1 peptidic receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1880554